Latest AstraZeneca Pharma stock price
AstraZeneca Pharma P/E Ratio
ASTRAZEN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
108.76
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
108.76
Current Price
₹8760.00
EPS (TTM)
₹46.30
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
48.93
Sector Median
25.71
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for AstraZeneca Pharma
- Stock appears overvalued with PE of 108.76, suggesting caution for new investments
- Trading at premium to sector average PE of 48.93
View the ASTRAZEN equity price for detailed stock performance.
Related Pages for AstraZeneca Pharma
Additional stock information and data for ASTRAZEN
Sector P/E Ratio Comparison
Comparing AstraZeneca Pharma with other companies in Healthcare sector
Sector Average
48.93
Sector Median
25.71
Lowest P/E
0.97
Highest P/E
993.26
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 3.0 | ₹43 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.67 | ₹1,166 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| Galaxy Medicare | GML | 7.25 | ₹24 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.74 | ₹2,188 | Low |
| Zenith Drugs | ZENITHDRUG | 7.9 | ₹76 | Low |
| Brooks Laboratories | BROOKS | 8.01 | ₹184 | Low |
| Vasundhara Rasayans | VRL | 9.97 | ₹37 | Low |